Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 442

1.

[Treatment of primary disease (breast, non-small cell lung and prostate cancers) with irradiation in case of de novo metastatic cancer].

Latorzeff I, Bourgier C, Pinel B, Hennequin C, Jimenez G, Chapet O, Zasadny X.

Cancer Radiother. 2019 Oct;23(6-7):486-495. doi: 10.1016/j.canrad.2019.08.004. Epub 2019 Sep 6. Review. French.

PMID:
31501025
2.

Combination of chemotherapy and radiotherapy: A thirty years evolution.

Hennequin C, Guillerm S, Quero L.

Cancer Radiother. 2019 Oct;23(6-7):662-665. doi: 10.1016/j.canrad.2019.07.157. Epub 2019 Aug 28. Review.

PMID:
31473087
3.

[Stereotactic ablative body radiotherapy: Which machine for which therapeutic indication? A focus on prostate cancer].

Lapierre A, Horn S, Créhange G, Enachescu C, Latorzeff I, Supiot S, Sargos P, Hennequin C, Chapet O.

Cancer Radiother. 2019 Oct;23(6-7):651-657. doi: 10.1016/j.canrad.2019.06.009. Epub 2019 Aug 22. Review. French.

PMID:
31447340
4.

Rationale for hypofractionation.

Hennequin C, Guillerm S, Quero L.

Cancer Radiother. 2019 Oct;23(6-7):500-502. doi: 10.1016/j.canrad.2019.07.156. Epub 2019 Aug 20. Review.

PMID:
31444076
5.

Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting.

Paccoud O, Guitard J, Labopin M, Surgers L, Malard F, Battipaglia G, Duléry R, Hennequin C, Mohty M, Brissot E.

Bone Marrow Transplant. 2019 Aug 21. doi: 10.1038/s41409-019-0641-y. [Epub ahead of print]

PMID:
31435031
6.

[Follow-up after rectal cancer treatment].

Quéro L, Guillerm S, Castelnau-Marchand P, Labidi M, Hennequin C.

Cancer Radiother. 2019 Oct;23(6-7):572-575. doi: 10.1016/j.canrad.2019.07.123. Epub 2019 Aug 14. French.

PMID:
31422001
7.

Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancer.

Amestoy F, Roubaud G, Antoine M, Fonteyne V, Baumann BC, Christodouleas J, Roupret M, Azria D, Zilli T, Hennequin C, Xylinas E, Sargos P; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology.

Crit Rev Oncol Hematol. 2019 Oct;142:76-85. doi: 10.1016/j.critrevonc.2019.06.010. Epub 2019 Jul 16. Review.

PMID:
31377435
8.

French recommendations on strategies for preventing and treating osteoporosis induced by adjuvant breast cancer therapies.

Bouvard B, Confavreux CB, Briot K, Bonneterre J, Cormier C, Cortet B, Hannoun-Lévi JM, Hennequin C, Javier RM, Kerbrat P, Lespessailles E, Lesur A, Mayeur D, Paccou J, Trémollières F, Vieillard MH, Debiais F.

Joint Bone Spine. 2019 Jul 25. pii: S1297-319X(19)30111-3. doi: 10.1016/j.jbspin.2019.07.005. [Epub ahead of print]

PMID:
31352137
9.

Salvage cryoablation for local recurrence of prostatic cancer after curative therapy.

Barat M, Colleter L, Mongiat-Artus P, Jolibois Z, Quero L, Hennequin C, Desgrandchamps F, de Kerviler E.

Diagn Interv Imaging. 2019 Jul 19. pii: S2211-5684(19)30166-4. doi: 10.1016/j.diii.2019.07.001. [Epub ahead of print]

PMID:
31331832
10.

[Toxicity of multimodal regimens in prostate cancer].

Hennequin C.

Prog Urol. 2019 Jun;29 Suppl 1:S35-S41. doi: 10.1016/S1166-7087(19)30168-X. French.

PMID:
31307629
11.

Dirofilariasis: a parasitic cause of subcutaneous nodule.

Wendum D, Campa P, Develoux M, Zmuda M, Putterman M, Hennequin C.

Clin Microbiol Infect. 2019 Oct;25(10):1231-1232. doi: 10.1016/j.cmi.2019.06.015. Epub 2019 Jun 20. No abstract available.

PMID:
31229594
12.

Candida auris, an emerging and disturbing yeast.

Coste AT, Imbert C, Hennequin C.

J Mycol Med. 2019 Jun;29(2):105-106. doi: 10.1016/j.mycmed.2019.05.002. No abstract available.

PMID:
31178041
13.

Is Capillary Electrophoresis a New Tool to Monitor Acute Lithium Poisoning in Human?†.

Jamal T, Hennequin C, Gahoual R, Leyris A, Beaudeux JL, Baud FJ, Houzé P.

J Anal Toxicol. 2019 Aug 23;43(7):571-578. doi: 10.1093/jat/bkz013.

PMID:
30877800
14.

Anti-PD-1 immunotherapy in combination with sequential involved-site radiotherapy in heavily pretreated refractory Hodgkin lymphoma.

Quéro L, Gilardin L, Fumagalli I, Martin V, Guillerm S, Bauduceau O, Kirova YM, Hennequin C, Brice P.

Cancer Radiother. 2019 Apr;23(2):132-137. doi: 10.1016/j.canrad.2018.05.002. Epub 2019 Feb 4.

PMID:
30733172
15.

Early metabolic response to chemoradiotherapy by interim FDG PET/CT is associated with better overall survival and histological response in esophageal cancers.

Hammoudi N, Hennequin C, Vercellino L, Costantini A, Valverde A, Cattan P, Quéro L.

Dig Liver Dis. 2019 Jun;51(6):887-893. doi: 10.1016/j.dld.2018.12.006. Epub 2018 Dec 23.

PMID:
30630738
16.

Criteria for indication and treatment modification in a cohort of patients with prostate cancer treated with hormone therapy.

Lebret T, Ruffion A, Latorzeff I, Zerbib M, Moreau JL, Rossi D, Pello-Leprince-Ringuet N, Perrot V, Hennequin C.

Ther Adv Urol. 2018 Oct 24;10(12):365-376. doi: 10.1177/1756287218808496. eCollection 2018 Dec.

17.

RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate French ccAFU guidelines – Update 2018–2020: Prostate cancer

Rozet F, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mongiat-Artus P, Ploussard G, Mathieu R, Brureau L, Ouzzane A, Azria D, Brenot-Rossi I, Cancel-Tassin G, Cussenot O, Rebillard X, Lebret T, Soulié M, Penna RR, Méjean A.

Prog Urol. 2018 Nov;28(12S):S79-S130. doi: 10.1016/j.purol.2018.08.011. Epub 2018 Nov 2. Review. French.

PMID:
30392712
18.

[Siriade 2.0: An e-learning platform for radiation oncology contouring].

Bibault JE, Denis F, Roué A, Gibon D, Fumagalli I, Hennequin C, Barillot I, Quéro L, Paumier A, Mahé MA, Servagi Vernat S, Créhange G, Lapeyre M, Blanchard P, Pointreau Y, Lafond C, Huguet F, Mornex F, Latorzeff I, de Crevoisier R, Martin V, Kreps S, Durdux C, Antoni D, Noël G, Giraud P.

Cancer Radiother. 2018 Dec;22(8):773-777. doi: 10.1016/j.canrad.2018.02.003. Epub 2018 Oct 22. French.

PMID:
30360973
19.

Human Bronchial Epithelial Cells Inhibit Aspergillus fumigatus Germination of Extracellular Conidia via FleA Recognition.

Richard N, Marti L, Varrot A, Guillot L, Guitard J, Hennequin C, Imberty A, Corvol H, Chignard M, Balloy V.

Sci Rep. 2018 Oct 24;8(1):15699. doi: 10.1038/s41598-018-33902-0.

20.

Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia.

Guilhen M, Hennequin C, Ouzaid I, Fumagalli I, Martin V, Guillerm S, Mongiat-Artus P, Ravery V, Desgrandchamps F, Quéro L.

Radiat Oncol. 2018 Oct 24;13(1):209. doi: 10.1186/s13014-018-1149-0.

21.

Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patients.

Marret G, Doucet L, Hennequin C, Fizazi K, Culine S.

Cancer Treat Res Commun. 2018;17:37-42. doi: 10.1016/j.ctarc.2018.10.001. Epub 2018 Oct 16.

PMID:
30347333
22.

French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation.

Briot K, Paccou J, Beuzeboc P, Bonneterre J, Bouvard B, Confavreux CB, Cormier C, Cortet B, Hannoun-Lévi JM, Hennequin C, Javier RM, Lespessailles E, Mayeur D, Mongiat Artus P, Vieillard MH, Debiais F.

Joint Bone Spine. 2019 Jan;86(1):21-28. doi: 10.1016/j.jbspin.2018.09.017. Epub 2018 Oct 1.

PMID:
30287350
23.

Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8+ T cells.

Desgrandchamps F, LeMaoult J, Goujon A, Riviere A, Rivero-Juarez A, Djouadou M, de Gouvello A, Dumont C, Wu CL, Culine S, Verine J, Rouas-Freiss N, Hennequin C, Masson-Lecomte A, Carosella ED.

Oncotarget. 2018 Sep 4;9(69):33160-33169. doi: 10.18632/oncotarget.26036. eCollection 2018 Sep 4.

24.

One fungus, several microbes.

Imbert C, Hennequin C, Coste A.

J Mycol Med. 2018 Sep;28(3):413. doi: 10.1016/j.mycmed.2018.08.001. No abstract available.

PMID:
30201134
25.

Image Gallery: A new source of zoophilic dermatophyte infection.

Touitou R, Bachmeyer C, Hennequin C, Moreno-Sabater A.

Br J Dermatol. 2018 Jul;179(1):e4. doi: 10.1111/bjd.16685. No abstract available.

PMID:
30156290
26.

Palliative Radiotherapy for Disfiguring Mycosis Fungoides Lesion: A Key Treatment to Reduce Psychological and Social Impact.

Egal A, Ram-Wolf C, Quero L, Bagot M, Vignon-Pennamen MD, Hennequin C, M'Barek B.

Case Rep Dermatol Med. 2018 Jul 26;2018:1762050. doi: 10.1155/2018/1762050. eCollection 2018.

27.

[Hypofractionnated radiotherapy for elderly patients with prostate cancer].

Sargos P, Créhange G, Hennequin C, Latorzeff I, de Crevoisier R, Roubaud G, Supiot S.

Cancer Radiother. 2018 Oct;22(6-7):631-634. doi: 10.1016/j.canrad.2018.07.124. Epub 2018 Aug 23. Review. French.

PMID:
30145092
28.

The sentinel lymph node of breast cancer and the radiation oncologist.

Hennequin C, Guillerm S, Quéro L.

Cancer Radiother. 2018 Oct;22(6-7):473-477. doi: 10.1016/j.canrad.2018.06.012. Epub 2018 Aug 20. Review.

PMID:
30139693
29.

Diversity of DHA-1-encoding plasmids in Klebsiella pneumoniae isolates from 16 French hospitals.

Hennequin C, Chlilek A, Beyrouthy R, Bonnet R, Robin F.

J Antimicrob Chemother. 2018 Nov 1;73(11):2981-2989. doi: 10.1093/jac/dky285.

PMID:
30060165
30.

Assessment of Architect cSystems Abbott® for the colorimetric measurement of lithium in urines and dyalisates.

Hennequin C, Jamal T, Leyris A, Beaudeux JL, Houzé P.

Clin Chem Lab Med. 2018 Oct 25;56(11):262-264. doi: 10.1515/cclm-2018-0175. No abstract available.

PMID:
29990303
31.

Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives.

Alastruey-Izquierdo A, Cadranel J, Flick H, Godet C, Hennequin C, Hoenigl M, Kosmidis C, Lange C, Munteanu O, Page I, Salzer HJF; on behalf of CPAnet.

Respiration. 2018;96(2):159-170. doi: 10.1159/000489474. Epub 2018 Jul 6. Review.

32.

Editorial.

Coste A, Imbert C, Hennequin C.

J Mycol Med. 2018 Jun;28(2):235. doi: 10.1016/j.mycmed.2018.06.001. No abstract available.

PMID:
29907372
33.

Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group.

Meyer E, Pasquier D, Bernadou G, Calais G, Maroun P, Bossi A, Theodore C, Albiges L, Stefan D, de Crevoisier R, Hennequin C, Lagrange JL, Grellard JM, Clarisse B, Licaj I, Habrand JL, Carrie C, Joly F.

Eur J Cancer. 2018 Jul;98:38-47. doi: 10.1016/j.ejca.2018.04.008. Epub 2018 Jun 1.

PMID:
29864737
34.

Endoluminal brachytherapy: Bronchus and oesophagus.

Hennequin C, Guillerm S, Wong S, Quéro L.

Cancer Radiother. 2018 Jun;22(4):367-371. doi: 10.1016/j.canrad.2017.11.013. Epub 2018 May 30. Review.

PMID:
29858135
35.

[French CCAFU guidelines on prostate cancer: hormono-naive metastatic prostate cancer - update 2017].

Rozet F, Hennequin C, Mongiat-Artus P, Beuzeboc P, Beauval JB, Cormier L, Fromont-Hankard G, Ouzzane A, Ploussard G, Renard-Penna R, Méjean A.

Prog Urol. 2018 May;28(6):303-306. doi: 10.1016/j.purol.2018.03.006. Epub 2018 Apr 19. French. No abstract available.

PMID:
29680190
36.

Plasmids carrying DHA-1 β-lactamases.

Hennequin C, Ravet V, Robin F.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1197-1209. doi: 10.1007/s10096-018-3231-9. Epub 2018 Apr 17. Review.

PMID:
29663096
37.

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.

Bourgier C, Castan F, Riou O, Nguyen TD, Peignaux K, Lemanski C, Lagrange JL, Kirova Y, Lartigau E, Belkacemi Y, Rivera S, Noël G, Clippe S, Mornex F, Hennequin C, Gourgou S, Brengues M, Fenoglietto P, Ozsahin EM, Azria D.

Oncotarget. 2018 Mar 2;9(21):15757-15765. doi: 10.18632/oncotarget.24606. eCollection 2018 Mar 20.

38.

Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendations.

Langrand-Escure J, de Crevoisier R, Llagostera C, Créhange G, Delaroche G, Lafond C, Bonin C, Bideault F, Sargos P, Belhomme S, Pasquier D, Latorzeff I, Supiot S, Hennequin C.

Cancer Radiother. 2018 Apr;22(2):193-198. doi: 10.1016/j.canrad.2017.11.004. Epub 2018 Apr 5.

PMID:
29628205
39.

Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer.

El Mouatani A, Rotaru I, Beaudeux JL, Hennequin C.

Ann Biol Clin (Paris). 2018 Jun 1;76(3):308-312. doi: 10.1684/abc.2018.1325.

PMID:
29622524
40.

Outcomes of radiation therapy of indolent cutaneous B-cell lymphomas and literature review.

Gauci ML, Quero L, Ram-Wolff C, Guillerm S, M'Barek B, Lebbé C, Bagot M, Hennequin C.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1668-1673. doi: 10.1111/jdv.14972. Epub 2018 May 18. Review.

PMID:
29578630
41.

Burden of Severe Fungal Infections in Burkina Faso.

Bamba S, Zida A, Sangaré I, Cissé M, Denning DW, Hennequin C.

J Fungi (Basel). 2018 Mar 11;4(1). pii: E35. doi: 10.3390/jof4010035.

42.

Loco-regional treatment for castration-resistant prostate cancer: Is there any rationale? A critical review from the AFU-GETUG.

Beauval JB, Loriot Y, Hennequin C, Rozet F, Barthelemy P, Borchiellini D, Schlürmann Constans F, Gross E, Maillet D, Pasticier G, Pignot G, Timsit MO, Vincendeau S, Ploussard G, Sargos P.

Crit Rev Oncol Hematol. 2018 Feb;122:144-149. doi: 10.1016/j.critrevonc.2017.12.012. Epub 2017 Dec 30. Review.

PMID:
29458782
43.

Species Identification and In Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter Study.

Imbert S, Normand AC, Ranque S, Costa JM, Guitard J, Accoceberry I, Bonnal C, Fekkar A, Bourgeois N, Houzé S, Hennequin C, Piarroux R, Dannaoui E, Botterel F.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02315-17. doi: 10.1128/AAC.02315-17. Print 2018 May.

44.

Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.

Guitard J, Isnard F, Tabone MD, Antignac M, Brissot E, Senghor Y, Petit A, Leverger G, Hennequin C.

J Infect. 2018 May;76(5):483-488. doi: 10.1016/j.jinf.2018.01.011. Epub 2018 Feb 9.

PMID:
29432826
45.

Receiver operating characteristic curve analysis of four Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis.

Page ID, Baxter C, Hennequin C, Richardson MD, van Hoeyveld E, van Toorenenbergen AW, Denning DW.

Diagn Microbiol Infect Dis. 2018 May;91(1):47-51. doi: 10.1016/j.diagmicrobio.2018.01.001. Epub 2018 Jan 6.

PMID:
29398462
46.

The Case | Acute kidney injury, flank pain, and kidney calcifications in an 80-year-old woman.

Sakhi H, Adjaoud D, Hennequin C, Fontaine E, Correas JM, Joint-Lambert O, Meria P, Joly D, Zaidan M.

Kidney Int. 2018 Feb;93(2):527-528. doi: 10.1016/j.kint.2017.08.017. No abstract available.

PMID:
29389401
47.

Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH).

Matysiak-Budnik T, Fabiani B, Hennequin C, Thieblemont C, Malamut G, Cadiot G, Bouché O, Ruskoné-Fourmestraux A.

Dig Liver Dis. 2018 Feb;50(2):124-131. doi: 10.1016/j.dld.2017.12.006. Epub 2017 Dec 18. Review.

PMID:
29301732
48.

Determination of procalcitonin (PCT) in micro-method on AQT90 FLEX® analyzer and in vitro stability study.

Mine L, Petit M, Nivet-Antoine V, Beaudeux JL, Hennequin C.

Ann Biol Clin (Paris). 2018 Jan 1;76(1):53-59. doi: 10.1684/abc.2017.1308.

PMID:
29199155
49.

Plesiobrachytherapy for chest wall recurrences of breast cancer after mastectomy and radiotherapy for breast cancer.

Besson N, Hennequin C, Guillerm S, Fumagalli I, Martin V, Michaud S, Texeira L, Quero L.

Brachytherapy. 2018 Mar - Apr;17(2):425-431. doi: 10.1016/j.brachy.2017.10.005. Epub 2017 Nov 23.

PMID:
29174938
50.

A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention.

Godet C, Alastruey-Izquierdo A, Flick H, Hennequin C, Mikilps-Mikgelbs R, Munteanu O, Page I, Seidel D, Salzer HJF; CPAnet.

J Antimicrob Chemother. 2018 Feb 1;73(2):280-286. doi: 10.1093/jac/dkx390. Review.

PMID:
29126309

Supplemental Content

Loading ...
Support Center